GlassScriptPhysician profile
Dusan A Stanojevic
NPI 1770782229
$3,564.27
in general payments reported to CMS, 2019-2025
17 companies · $399 in 2025
The $399 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $1,598 · 2021: $122 · 2022: $449 · 2023: $71.87 · 2024: $623 · 2025: $399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,094.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,094.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,819.65 | 2019-2020 | |
| Boston Scientific Corporation | $527.05 | 2019-2024 | Avvigo Guidance System, Watchman Flx |
| Medtronic, INC. | $411.99 | 2021-2025 | Corevalve Evolut R, Na, Micra |
| Abbott Laboratories | $369.06 | 2021-2025 | Optis, Nc Trek Neo, Pressurewire |
| Cardiva Medical, INC. | $126.24 | 2024 | Cardiva Vascade 6/7f Vcs |
| Edwards Lifesciences Corporation | $43.14 | 2019-2021 | |
| Amgen INC. | $42.94 | 2024-2025 | Repatha, Repatha |
| Impulse Dynamics (USA) INC. | $33.35 | 2025 | Optimizer |
| Novartis Pharmaceuticals Corporation | $32.00 | 2025 | |
| Abiomed | $30.34 | 2021-2025 | |
| Astellas Pharma US INC | $23.09 | 2019 | |
| Asahi Intecc USA, INC. | $22.14 | 2025 | Asahi Peripheral Vascular Wires |
| Biotronik INC. | $20.71 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.25 | 2025 | Jardiance |
| Penumbra, INC. | $16.59 | 2025 | Indigo System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $14.86 | 2024 | Zio Xt Patch, Zio Monitor |
| W. L. Gore & Associates, INC. | $13.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dusan Stanojevic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.